Shares of Elan Corporation Plc (ADR) (NYSE: ELN), a neuroscience-based biotechnology company, are soaring in trading today after the company received a takeover offer from Royalty Pharma.
Continue reading Major Movers on February 25; ELN, DDD, HTZ, DDS